» Articles » PMID: 33224436

Protective Potential of Curcumin in L-NAME-induced Hypertensive Rat Model: AT1R, Mitochondrial DNA Synergy

Overview
Date 2020 Nov 23
PMID 33224436
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Objectives: Hypertension can be induced by inhibiting nitric oxide synthesis with L-NAME, which also has a role in oxidative stress. Curcumin has strong antioxidant property. Our aim was to examine the possible preventive role of curcumin on renal dysfunction secondary to hypertension.

Material & Methods: Twenty-four adult male Albino rats were divided in four groups: normal (N); curcumin (C; received curcumin 100 mg/kg/day by oral gavage for 10 weeks); hypertensive (H; received L-NAME 40 mg/kg/day in their drinking water for 4 weeks); and hypertensive-curcumin (HC; received L-NAME and curcumin). Arterial blood pressure was evaluated non-invasively for 4 weeks. Rats were then sacrificed for assessment of oxidative stress (catalase, lipid peroxidase, reduced glutathione and superoxide dismutase), renal function and structure, and biomarkers of apoptosis (Bcl-2 and caspase-3). AT1R expression and renal mtDNA integrity were also assessed.

Results: Curcumin attenuated the effects of L-NAME on blood pressure and renal function. The renal histopathological changes observed in the L-NAME group were improved by curcumin administration. The expression of Bcl2 and caspase-3 was improved associated with downregulation of AT1R in curcumin treated groups. The antioxidant markers and mtDNA fragmentation show marked increase in hypertensive group which significantly decreased after curcumin treatment.

Conclusion: Curcumin improved blood pressure elevation renal dysfunction. These improvements mediated through anti-oxidant capabilities and downregulation of AT1R favoring reduced apoptosis and preserved mitochondrial DNA.

Citing Articles

Exploring synergistic effects of Blume and Pall. on hypertension with liver yang hyperactivity using the multidisciplinary integrative strategy.

Zhang Y, Yan P, He Y, Ren S, Wu D, Wang Y Heliyon. 2024; 10(21):e38649.

PMID: 39524820 PMC: 11550124. DOI: 10.1016/j.heliyon.2024.e38649.


Natural compounds targeting mitochondrial dysfunction: emerging therapeutics for target organ damage in hypertension.

Liao X, Han Y, He Y, Liu J, Wang Y Front Pharmacol. 2023; 14:1209890.

PMID: 37397478 PMC: 10311420. DOI: 10.3389/fphar.2023.1209890.


The effect of curcumin on blood pressure and cognitive impairment in spontaneously hypertensive rats.

Lim J, Kim W, Ha A Nutr Res Pract. 2023; 17(2):192-205.

PMID: 37009141 PMC: 10042717. DOI: 10.4162/nrp.2023.17.2.192.


New Therapeutic Insight into the Effect of Ma Huang Tang on Blood Pressure and Renal Dysfunction in the L-NAME-Induced Hypertension.

Hong M, Kim H, Jang Y, Na S, Han B, Yoon J Evid Based Complement Alternat Med. 2021; 2021:9980429.

PMID: 34335852 PMC: 8294972. DOI: 10.1155/2021/9980429.

References
1.
Gupta S, Prasad S, Kim J, Patchva S, Webb L, Priyadarsini I . Multitargeting by curcumin as revealed by molecular interaction studies. Nat Prod Rep. 2011; 28(12):1937-55. PMC: 3604998. DOI: 10.1039/c1np00051a. View

2.
Emans T, Janssen B, Pinkham M, Ow C, Evans R, Joles J . Exogenous and endogenous angiotensin-II decrease renal cortical oxygen tension in conscious rats by limiting renal blood flow. J Physiol. 2016; 594(21):6287-6300. PMC: 5088249. DOI: 10.1113/JP270731. View

3.
Tsukahara H, Hiraoka M, Kobata R, Hata I, Ohshima Y, Jiang M . Increased oxidative stress in rats with chronic nitric oxide depletion: measurement of urinary 8-hydroxy-2'-deoxyguanosine excretion. Redox Rep. 2000; 5(1):23-8. DOI: 10.1179/rer.2000.5.1.23. View

4.
Nakmareong S, Kukongviriyapan U, Pakdeechote P, Kukongviriyapan V, Kongyingyoes B, Donpunha W . Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency. Hypertens Res. 2011; 35(4):418-25. DOI: 10.1038/hr.2011.180. View

5.
Vaziri N, Bai Y, Ni Z, Quiroz Y, Pandian R, Rodriguez-Iturbe B . Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. J Pharmacol Exp Ther. 2007; 323(1):85-93. DOI: 10.1124/jpet.107.123638. View